Director, US Value, Access, and Pricing Strategy
Orca BioSalary not specified
Full Time
Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
YesVisa
Biotech, In Vitro DiagnosticsIndustries
Requirements
The Senior Director, Market Access should spearhead the development and execution of market access strategies to enhance patient access, secure reimbursement, and encourage product adoption, leading coding, coverage, and pricing initiatives, crafting access, reimbursement, and contracting strategies for various payer segments and geographies, and performing pricing analysis and modeling to establish optimal pricing and contracting.
Responsibilities
This role will be instrumental in crafting and executing market access strategies for the successful commercialization of Freenome’s CRC screening test, identifying and building out the appropriate team to support market access goals, and ensuring reimbursement for the product upon FDA approval and future product pipeline development.
Skills
Market Access
Reimbursement
IVD
Commercialization
Strategy
Patient Care
Cross-collaboration
Freenome
Biotechnology company for early cancer detection
About Freenome
Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.
San Francisco, CaliforniaHeadquarters
2014Year Founded
$1,032.6MTotal Funding
LATE_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees
Benefits
Competitive market-based salaries
Annual bonus opportunities
Relocation packages
Medical, dental, & vision coverage
401k
Wellness programs
Equity
PTO
Risks
Employee layoffs may affect morale and innovation efforts.
Integration of Oncimmune Ltd. could divert focus from core projects.
Competitive landscape in cancer detection may impact Freenome's market share.
Differentiation
Freenome uses a unique multiomics approach for early cancer detection.
The company focuses on non-invasive blood tests for cancer screening.
Freenome's platform designs personalized health conditions based on cell-free genome analysis.
Upsides
Recent $254 million funding boosts clinical programs and platform expansion.
Partnership with Walgreens enhances clinical trial diversity and patient recruitment.
PROACT LUNG study positions Freenome as a leader in lung cancer diagnostics.
Related Jobs
RemoteRemoteAccount Manager, Payer
Maven ClinicSalary not specified
- Full Time
- Mid-level (3 to 4 years), Senior (5 to 8 years)
RemoteField Reimbursement and Market Access Manager
PROCEPT BioRoboticsSalary not specified
- Full Time
- Senior (5 to 8 years)
RemoteAssociate Director, Government Pricing
Model NSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteSenior Director, Value & Access (Pharmaceutical / Payer)
The Lockwood Group, LLCSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteDirector of Policy
GoodleapSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteHealth Plan Partnerships Director
ColorSalary not specified
- Full Time
- Junior (1 to 2 years)